Amneal Pharmaceuticals Inc Class A (AMRX)

5.520 -0.170 (-2.99%)
Close USD Disclaimer
5.520 0.000 (0.000%)

AMRX Earnings

Title
Quarterly
Annually
Latest Release Mar 01, 2024 Dec 31, 2023
EPS
0.14 0.09
-0.48
Revenue
617M 634.89M
2.39B
Next release Date May 03, 2024 -
Expected growth -5.07% -
Clear All
0Selected
Please try another search
EPS
Revenue
Historical Earnings
EPS
Revenue
Forecast
Release Date
Period End
EPS Actual
EPS Forecast
EPS Surprise
Revenue Actual
Revenue Forecast
Revenue Surprise
May 05, 2023 03/2023 0.12 0.09 +0.03 558M 542.27M +15.73
Mar 02, 2023 12/2022 0.23 0.21 +0.02 610M 579.84M +30.16
Nov 04, 2022 09/2022 0.14 0.18 -0.04 546M 561.86M -15.86
Aug 05, 2022 06/2022 0.19 0.1944 -0 559.36M 534.49M +24.87
May 04, 2022 03/2022 0.12 0.1286 -0.01 497.63M 502.29M -4.66
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.

Related Articles